eConsent Resources

  1. The Right EDC Solution For Oncology Trials 5/19/2023

    Oncology clinical trials can be very complex, as are their data management needs. Understand why selecting the right EDC is crucial for managing them efficiently while providing compassionate care.

  2. Flexible By Design: Support For Early-Phase Oncology Trial 7/8/2026

    Shifting cohorts, doses, and protocols challenge early-phase oncology trials. Learn how adaptable technology keeps studies on track.

  3. Re-Consent In Clinical Trials: Streamlining With eConsent 11/29/2023

    Delve into a variety of triggers for initiating re-consent, perspectives of regulators and IRBs regarding the re-consent process, and the role of digital processes in preventing issues related to re-consent.

  4. Combining Patient-Centric Technology and RWD For Comprehensive Evidence 8/10/2022

    Explore how by combining digital technologies with secondary RWD, researchers can gather a more holistic understanding of the patient. 

  5. The Win-Win Wth Virtual Visits – Better Experiences, Better Data 2/29/2024

    Discover how researchers can design studies with the needs of the patient in mind to promote faster enrollment, high engagement, and the production of more complete and accurate data.

  6. Protocol Amendments And Electronic Consent: Overcoming The Challenges To Reap The Benefits 3/29/2022

    Learn about some insights that have been gleaned from experience deploying eConsent on diverse trial types around the world.

  7. Addressing The Specific Complexities Of Oncology eCOA Clinical Trials 4/18/2022

    What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.

  8. How eConsent Primes Patients And Studies For Success 9/14/2022

    Understand how the informed consent process ensures trial participants are adequately educated about the trial and what's required of them during the process while confirming their willingness to enroll.

  9. How Partnership Ensured A Successful First Digital Trial 5/1/2024

    Discover how this collaborative approach and tailored recommendations led to the successful implementation of an eConsent tool for a kidney cancer study with U.S. Renal Care.

  10. Our Unified Platform Serves As eSource For COVID Treatment Trial 6/17/2024

    Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.